[HTML][HTML] Clinical application of the AUC-guided dosage adjustment of docetaxel-based chemotherapy for patients with solid tumours: a single centre, prospective and …
N Sun, B Shen, J Zhu, X Zhang, H Zhu, G Liang… - Journal of Translational …, 2020 - Springer
Background Docetaxel (DTX) is a widely used anti-tumour drug, and its dosage is solely
determined by body surface area (BSA). Adverse events, such as neutropenia or unsatisfied …
determined by body surface area (BSA). Adverse events, such as neutropenia or unsatisfied …
[引用][C] Clinical application of the AUC-guided dosage adjustment of docetaxel-based chemotherapy for patients with solid tumours: a single centre, prospective and …
N Sun, B Shen, J Zhu, X Zhang, H Zhu… - Journal of …, 2020 - jglobal.jst.go.jp
Clinical application of the AUC-guided dosage adjustment of docetaxel-based
chemotherapy for patients with solid tumours: a single centre, prospective and randomised …
chemotherapy for patients with solid tumours: a single centre, prospective and randomised …
[HTML][HTML] Clinical application of the AUC-guided dosage adjustment of docetaxel-based chemotherapy for patients with solid tumours: a single centre, prospective and …
N Sun, B Shen, J Zhu, X Zhang, H Zhu… - Journal of …, 2020 - ncbi.nlm.nih.gov
Background Docetaxel (DTX) is a widely used anti-tumour drug, and its dosage is solely
determined by body surface area (BSA). Adverse events, such as neutropenia or unsatisfied …
determined by body surface area (BSA). Adverse events, such as neutropenia or unsatisfied …
Clinical application of the AUC-guided dosage adjustment of docetaxel-based chemotherapy for patients with solid tumours: a single centre, prospective and …
N Sun, B Shen, J Zhu, X Zhang, H Zhu, G Liang… - 2020 - pubmed.ncbi.nlm.nih.gov
Background Docetaxel (DTX) is a widely used anti-tumour drug, and its dosage is solely
determined by body surface area (BSA). Adverse events, such as neutropenia or unsatisfied …
determined by body surface area (BSA). Adverse events, such as neutropenia or unsatisfied …
[HTML][HTML] Clinical application of the AUC-guided dosage adjustment of docetaxel-based chemotherapy for patients with solid tumours: a single centre, prospective and …
N Sun, B Shen, J Zhu, X Zhang… - Journal of …, 2020 - … -medicine.biomedcentral.com
Docetaxel (DTX) is a widely used anti-tumour drug, and its dosage is solely determined by
body surface area (BSA). Adverse events, such as neutropenia or unsatisfied efficacy, likely …
body surface area (BSA). Adverse events, such as neutropenia or unsatisfied efficacy, likely …
Clinical application of the AUC-guided dosage adjustment of docetaxel-based chemotherapy for patients with solid tumours: a single centre, prospective and …
N Sun, B Shen, J Zhu, X Zhang, H Zhu… - Journal of …, 2020 - go.gale.com
Background Docetaxel (DTX) is a widely used anti-tumour drug, and its dosage is solely
determined by body surface area (BSA). Adverse events, such as neutropenia or unsatisfied …
determined by body surface area (BSA). Adverse events, such as neutropenia or unsatisfied …
Clinical application of the AUC-guided dosage adjustment of docetaxel-based chemotherapy for patients with solid tumours: a single centre, prospective and …
N Sun, B Shen, J Zhu, X Zhang, H Zhu… - Journal of …, 2020 - europepmc.org
Background Docetaxel (DTX) is a widely used anti-tumour drug, and its dosage is solely
determined by body surface area (BSA). Adverse events, such as neutropenia or unsatisfied …
determined by body surface area (BSA). Adverse events, such as neutropenia or unsatisfied …
[PDF][PDF] Clinical application of the AUC-guided dosage adjustment of docetaxel-based chemotherapy for patients with solid tumours: a single centre, prospective and …
N Sun, B Shen, J Zhu, X Zhang, H Zhu, G Liang… - 2020 - scholar.archive.org
Background: Docetaxel (DTX) is a widely used anti-tumour drug, and its dosage is solely
determined by body surface area (BSA). Adverse events, such as neutropenia or unsatisfied …
determined by body surface area (BSA). Adverse events, such as neutropenia or unsatisfied …
Clinical application of the AUC-guided dosage adjustment of docetaxel-based chemotherapy for patients with solid tumours: a single centre, prospective and …
N Sun, B Shen, J Zhu, X Zhang, H Zhu… - Journal of …, 2020 - search.proquest.com
Background Docetaxel (DTX) is a widely used anti-tumour drug, and its dosage is solely
determined by body surface area (BSA). Adverse events, such as neutropenia or unsatisfied …
determined by body surface area (BSA). Adverse events, such as neutropenia or unsatisfied …
[PDF][PDF] Clinical application of the AUC-guided dosage adjustment of docetaxel-based chemotherapy for patients with solid tumours: a single centre, prospective and …
N Sun, B Shen, J Zhu, X Zhang, H Zhu, G Liang… - 2020 - … -medicine.biomedcentral.com
Background: Docetaxel (DTX) is a widely used anti-tumour drug, and its dosage is solely
determined by body surface area (BSA). Adverse events, such as neutropenia or unsatisfied …
determined by body surface area (BSA). Adverse events, such as neutropenia or unsatisfied …